Morgan BP - Search Results

1

Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities.

Harris CL, Spiller OB, Morgan BP. Harris CL, et al. Among authors: morgan bp. Immunology. 2000 Aug;100(4):462-70. doi: 10.1046/j.1365-2567.2000.00066.x. Immunology. 2000. PMID: 10929073 Free PMC article.

2

Membrane attack complex (MAC)-mediated damage to spermatozoa: protection of the cells by the presence on their membranes of MAC inhibitory proteins.

Rooney IA, Davies A, Morgan BP. Rooney IA, et al. Among authors: morgan bp. Immunology. 1992 Mar;75(3):499-506. Immunology. 1992. PMID: 1374057 Free PMC article.

3

Characterization of the membrane attack complex inhibitory protein CD59 antigen on human amniotic cells and in amniotic fluid.

Rooney IA, Morgan BP. Rooney IA, et al. Among authors: morgan bp. Immunology. 1992 Aug;76(4):541-7. Immunology. 1992. PMID: 1383132 Free PMC article.

4

Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.

Meri S, Morgan BP, Davies A, Daniels RH, Olavesen MG, Waldmann H, Lachmann PJ. Meri S, et al. Among authors: morgan bp. Immunology. 1990 Sep;71(1):1-9. Immunology. 1990. PMID: 1698710 Free PMC article.

5

Protection of human amniotic epithelial cells (HAEC) from complement-mediated lysis: expression on the cells of three complement inhibitory membrane proteins.

Rooney IA, Morgan BP. Rooney IA, et al. Among authors: morgan bp. Immunology. 1990 Nov;71(3):308-11. Immunology. 1990. PMID: 1702747 Free PMC article.

6

The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells.

Rooney IA, Davies A, Griffiths D, Williams JD, Davies M, Meri S, Lachmann PJ, Morgan BP. Rooney IA, et al. Among authors: morgan bp. Clin Exp Immunol. 1991 Feb;83(2):251-6. doi: 10.1111/j.1365-2249.1991.tb05623.x. Clin Exp Immunol. 1991. PMID: 1704296 Free PMC article.

7

Imaging Ca2+ changes in individual oligodendrocytes attacked by T-cell perforin.

Jones J, Frith S, Piddlesden S, Morgan BP, Compston DA, Campbell AK, Hallett MB. Jones J, et al. Among authors: morgan bp. Immunology. 1991 Dec;74(4):572-7. Immunology. 1991. PMID: 1783417 Free PMC article.

8

Complement deficiency and disease.

Morgan BP, Walport MJ. Morgan BP, et al. Immunol Today. 1991 Sep;12(9):301-6. doi: 10.1016/0167-5699(91)90003-C. Immunol Today. 1991. PMID: 1836729 Review.

9

Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation.

Piddlesden S, Lassmann H, Laffafian I, Morgan BP, Linington C. Piddlesden S, et al. Among authors: morgan bp. Clin Exp Immunol. 1991 Feb;83(2):245-50. doi: 10.1111/j.1365-2249.1991.tb05622.x. Clin Exp Immunol. 1991. PMID: 1993358 Free PMC article.

10

Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions.

Oleesky DA, Daniels RH, Williams BD, Amos N, Morgan BP. Oleesky DA, et al. Among authors: morgan bp. Clin Exp Immunol. 1991 May;84(2):250-5. Clin Exp Immunol. 1991. PMID: 2025952 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

535 results

Search Page

Filters